(-0.13%) 5 462.40 points
(-0.09%) 39 079 points
(0.11%) 17 737 points
(-0.63%) $80.32
(-4.32%) $2.64
(-0.77%) $2 312.90
(0.13%) $28.91
(2.33%) $1 009.40
(0.29%) $0.936
(0.70%) $10.68
(0.47%) $0.792
(-0.16%) $87.35
Live Chart Being Loaded With Signals
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer\'s and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer\'s disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection...
Stats | |
---|---|
Today's Volume | 272 208 |
Average Volume | 0 |
Market Cap | 70.45M |
EPS | $-0.000500 ( Q2 | 2022-08-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.658 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.242 (12.41%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-06-29 | Monohon Ted | Buy | 250 000 | Stock Option (right to buy) |
2022-06-09 | Bray June | Buy | 54 000 | Stock Option (right to buy) |
2022-06-09 | Bray June | Buy | 0 | |
2022-06-08 | Senner Christopher J. | Buy | 27 000 | Stock Option (right to buy) |
2022-06-08 | Ryan Una S | Buy | 27 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 94 transactions |
Buy: 5 069 399 | Sell: 426 503 |
Volume Correlation
Cortexyme, Inc. Correlation
10 Most Positive Correlations | |
---|---|
DLUSX | 0.863 |
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Cortexyme, Inc. Correlation - Currency/Commodity
Cortexyme, Inc. Financials
Annual | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.02 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-3.02 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-2.63 |
FY | 2019 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.940 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cortexyme, Inc.
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer\'s and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer\'s disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis, and coronavirus infection. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators